ACRO Biomedical (Taiwan) Performance
| 6748 Stock | 60.00 0.40 0.66% |
The firm shows a Beta (market volatility) of 0.23, which signifies not very significant fluctuations relative to the market. As returns on the market increase, ACRO Biomedical's returns are expected to increase less than the market. However, during the bear market, the loss of holding ACRO Biomedical is expected to be smaller as well. At this point, ACRO Biomedical has a negative expected return of -0.26%. Please make sure to confirm ACRO Biomedical's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if ACRO Biomedical performance from the past will be repeated in the future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ACRO Biomedical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2026. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
ACRO |
ACRO Biomedical Relative Risk vs. Return Landscape
If you would invest 6,790 in ACRO Biomedical Co on November 4, 2025 and sell it today you would lose (790.00) from holding ACRO Biomedical Co or give up 11.63% of portfolio value over 90 days. ACRO Biomedical Co is generating negative expected returns and assumes 1.955% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than ACRO, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ACRO Biomedical Target Price Odds to finish over Current Price
The tendency of ACRO Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 60.00 | 90 days | 60.00 | roughly 97.0 |
Based on a normal probability distribution, the odds of ACRO Biomedical to move above the current price in 90 days from now is roughly 97.0 (This ACRO Biomedical Co probability density function shows the probability of ACRO Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon ACRO Biomedical has a beta of 0.23. This suggests as returns on the market go up, ACRO Biomedical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ACRO Biomedical Co will be expected to be much smaller as well. Additionally ACRO Biomedical Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. ACRO Biomedical Price Density |
| Price |
Predictive Modules for ACRO Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ACRO Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ACRO Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ACRO Biomedical is not an exception. The market had few large corrections towards the ACRO Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ACRO Biomedical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ACRO Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.29 | |
β | Beta against Dow Jones | 0.23 | |
σ | Overall volatility | 2.29 | |
Ir | Information ratio | -0.16 |
ACRO Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ACRO Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ACRO Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ACRO Biomedical generated a negative expected return over the last 90 days |
Things to note about ACRO Biomedical performance evaluation
Checking the ongoing alerts about ACRO Biomedical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ACRO Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ACRO Biomedical generated a negative expected return over the last 90 days |
- Analyzing ACRO Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ACRO Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining ACRO Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ACRO Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ACRO Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ACRO Biomedical's stock. These opinions can provide insight into ACRO Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for ACRO Stock Analysis
When running ACRO Biomedical's price analysis, check to measure ACRO Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACRO Biomedical is operating at the current time. Most of ACRO Biomedical's value examination focuses on studying past and present price action to predict the probability of ACRO Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACRO Biomedical's price. Additionally, you may evaluate how the addition of ACRO Biomedical to your portfolios can decrease your overall portfolio volatility.